The DOI matches its Crossref record.
Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ETAReceptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors
Abstract
Background The importance of endothelin-1 in chronic heart failure (CHF) is unclear. We therefore investigated the effects of endothelin-converting enzyme (ECE) inhibition and endothelin ET A receptor blockade in CHF patients treated with ACE inhibitors. We also compared the function of ET A and ET B receptors in healthy subjects and patients with CHF. Methods and Results Locally active doses of study drugs were infused into the nondominant brachial artery while forearm blood flow (FBF) was measured by venous occlusion plethysmography. In CHF patients (n=10), phosphoramidon (a combined ECE and neutral endopeptidase inhibitor) and BQ-123 (an ET A receptor antagonist) increased FBF by 52±10% (P=.0006) and 31±6% (P=.002), respectively, and thiorphan (a selective neutral endopeptidase inhibitor) reduced FBF by 15±5% (P=.0007). Forearm vasoconstriction to endothelin-1 (an ET A and ET B receptor agonist) was significantly blunted in CHF patients compared with control subjects (both n=10; CHF versus control subjects,P<.001), whereas vasoconstriction to sarafotoxin S6c (an ET B receptor agonist) was significantly enhanced in CHF patients compared with control subjects (both n=10; CHF versus control subjects,P<.05). Conclusions ECE inhibitors and ET A receptor antagonists may be useful as vasodilator agents in CHF patients already receiving treatment with an ACE inhibitor. Both ET A and ET B receptors can mediate agonist-induced vasoconstriction in healthy subjects and patients with CHF, but further studies are required to clarify the contribution of each receptor subtype in mediating the effects of endogenous endothelin-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Lüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
Verhaar, M. C., Strachan, F. E., Newby, D. E., Cruden, N. L., Koomans, H. A., Rabelink, T. J., & Webb, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.8.752 · Cited by 453
Self-citationMoraes, D. L., Colucci, W. S., & Givertz, M. M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1718 · Cited by 401
Endothelin as a regulator of cardiovascular function in health and disease
Haynes, W. G., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816080-00001 · Cited by 360
Self-citation
Metadata
- Authors
- Love, M. P., Haynes, W. G., Gray, G. A., Webb, D. J., & McMurray, J. J. V.
- Venue
- Circulation
- Published
- 1996-11
- Volume
- 94
- Issue
- 9
- Pages
- 2131-2137
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2003967661
- Cited by
- 182
- References
- 0
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ETAReceptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors. https://app.cochat.ai/papers/10.1161/01.cir.94.9.2131
- The paper
- Love, M. P., Haynes, W. G., Gray, G. A., Webb, D. J., & McMurray, J. J. V. (1996). Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ETAReceptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors. Circulation. https://doi.org/10.1161/01.cir.94.9.2131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.